Alzheimer's Disease Risk

    Last Updated: October 13, 2024

    Alzheimer's disease is a neurodegenerative disease and the most common type of dementia. "Risk of Alzheimer's disease" is the likelihood of developing Alzheimer's disease.

    21,407 participants in 5 trials

    Examine Database: Alzheimer's Disease Risk

    Research FeedRead all studies

    Examine Database References

    1. Vitamin E - Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ, Alzheimer's Disease Cooperative Study GroupVitamin E and donepezil for the treatment of mild cognitive impairmentN Engl J Med.(2005 Jun 9)
    2. Ginkgo Biloba - DeKosky ST, Williamson JD, Fitzpatrick AL, Kronmal RA, Ives DG, Saxton JA, Lopez OL, Burke G, Carlson MC, Fried LP, Kuller LH, Robbins JA, Tracy RP, Woolard NF, Dunn L, Snitz BE, Nahin RL, Furberg CD; Ginkgo Evaluation of Memory (GEM) Study InvestigatorsGinkgo biloba for prevention of dementia: a randomized controlled trialJAMA.(2008 Nov 19)
    3. Ginkgo Biloba - Vellas B, Coley N, Ousset PJ, Berrut G, Dartigues JF, Dubois B, Grandjean H, Pasquier F, Piette F, Robert P, Touchon J, Garnier P, Mathiex-Fortunet H, Andrieu S, GuidAge Study GroupLong-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trialLancet Neurol.(2012 Oct)
    4. Vitamin E - Wang W, Li J, Zhang H, Wang X, Zhang XEffects of vitamin E supplementation on the risk and progression of AD: a systematic review and meta-analysis.Nutr Neurosci.(2021 Jan)
    5. Vitamin E - Farina N, Llewellyn D, Isaac MGEKN, Tabet NVitamin E for Alzheimer's dementia and mild cognitive impairment.Cochrane Database Syst Rev.(2017 Apr 18)